- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips upgrades 'big bore' CT at ASTRO
Enhancements that adjust for organ motion and better localize lesions debuted today for Philips’ Brilliance CT Big Bore at the American Society for Radiation Oncology (ASTRO) in Chicago.
Enhancements that adjust for organ motion and better localize lesions debuted today for Philips’ Brilliance CT Big Bore at the American Society for Radiation Oncology (ASTRO) in Chicago. Philips Healthcare framed the upgrades as speeding up diagnosis and improving the patient treatment planning, when scans are done on the company’s 85 cm large bore CT. Upgrades to the Brilliance CT Big Bore include RapidView 4-D Reconstruction System, which accelerates data processing; Amplitude Binning Algorithm, which adjusts for movement caused by respiration; Metal Artifact Reduction, designed to improve images resolution of sites near high density metal objects; “Sim Enhancement” Blocking Technology, which allows clinicians to mark an area for treatment and initiate treatment; and Tumor L.O.C. (Localization On Console), software that localizes and marks tumors in a simulation run at the scanner console.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
